AID Cann

Medical Cannabis Products

Health Tech & Life Sciences
Acquired by Limited 1498
Public Tel Aviv-Yafo, Israel Founded 1993
Last updated 2026-06-18
Total raised
$37.6M
Last: 2021-07
Stage
Public
Founded
1993
Headcount
13
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

AID Cann is a vertically integrated medical cannabis company focused on the cultivation, manufacture, distribution, and creation of products and dosage forms for medical cannabis products. The company holds initial licenses for the entire supply chain, including growing, breeding, and nursery; production of medical cannabis products; research and development; and distribution.

The company produces its own cannabis by way of a partnership with Amit Farms, which is located in the south of Israel and designated for cannabis growth. The farm uses innovative agricultural technologies to grow high-quality cannabis and to develop Univos strains designed to meet specific therapeutic needs.

AID Cann manufacturing facility produces a wide variety of medical cannabis products that meet the most stringent international standards. The plant is IMC-GMP certified and began production in Q3 2019. The company uses ethanol and CO2-based extraction technologies to manufacture a wide range of medical cannabis products. Additional technologies will be added to enable different delivery systems and dosages to meet the needs of the products in its R&D pipeline.

Funding history · 4 rounds · $37.6M total

Q&A

What is AID Cann's primary business focus?
AID Cann is a vertically integrated medical cannabis company that focuses on the cultivation, manufacture, distribution, and creation of medical cannabis products and dosage forms.
When was AID Cann founded?
AID Cann was founded in April 1993.
What is AID Cann's current status?
AID Cann was acquired by Limited 1498 in December 2024.
What was the amount of AID Cann's last funding round and when did it occur?
AID Cann raised $3,600,000 in July 2021.
Which investors participated in AID Cann's July 2021 funding round?
Nir Tzuk participated in AID Cann's July 2021 funding round.
What is AID Cann's total funding raised to date?
AID Cann has raised a total of $37,646,000 to date.
What certifications does AID Cann's manufacturing facility hold?
AID Cann's manufacturing facility is IMC-GMP certified and began production in Q3 2019.

Team · 3

Founder · Founder & Board Member
Founder · Founder
LinkedIn ↗
Founder · Co-founder & (Left the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisAgriculture & Food TechnologiesAg TechFarm Equipment & Treatment
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B2C

Highlights

1 Patents

Tags

pharmaceuticalsdegenerative-diseasesepilepsyneurologyagtechmedical-cannabisbreeding
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteaidcann.co.il/
LinkedInlinkedin.com/company/12614994
Instagraminstagram.com/univo_pharma

Identifiers & details

Former namesD-Pharm, Univo
Founded1993-4
Employees (exact)13
Market cap$790K
Status reasonAcquired by Limited 1498 on Dec, 2024

Acquisitions & public offerings

Acquired by Limited 1498 2024-12

Radar intelligence

Web history (Wayback)

Domainaidcann.co.il

Certificate / subdomain footprint

Subdomains6